ATE123948T1 - Antiviral use of compositions comprising efas and interferon. - Google Patents

Antiviral use of compositions comprising efas and interferon.

Info

Publication number: ATE123948T1
Authority: AT; Austria
Prior art keywords: efas; interferon; compositions; gamma; interferons
Prior art date: 1989-08-10

Application number

AT90308542T

Other languages

English (en)

Inventor

David Frederick C O S Horrobin

Meadows Woodbridge

Original Assignee

Scotia Holdings Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-10

Filing date

1990-08-02

Publication date

1995-07-15

1990-08-02 Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc

1995-07-15 Application granted granted Critical

1995-07-15 Publication of ATE123948T1 publication Critical patent/ATE123948T1/de

Links

102000014150 Interferons Human genes 0.000 title abstract 5
108010050904 Interferons Proteins 0.000 title abstract 5
230000000840 anti-viral effect Effects 0.000 title abstract 2
229940079322 interferon Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
229940047124 interferons Drugs 0.000 abstract 4
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 2
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 2
230000001093 anti-cancer Effects 0.000 abstract 2
230000003110 anti-inflammatory effect Effects 0.000 abstract 2
235000021342 arachidonic acid Nutrition 0.000 abstract 2
229940114079 arachidonic acid Drugs 0.000 abstract 2
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 2
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 2
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 2
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
229960002733 gamolenic acid Drugs 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT90308542T 1989-08-10 1990-08-02 Antiviral use of compositions comprising efas and interferon. ATE123948T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898918294A GB8918294D0 (en)	1989-08-10	1989-08-10	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ATE123948T1 true ATE123948T1 (de)	1995-07-15

Family

ID=10661451

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90308542T ATE123948T1 (de)	1989-08-10	1990-08-02	Antiviral use of compositions comprising efas and interferon.

Country Status (15)

Country	Link
US (1)	US5580556A (de)
EP (2)	EP0416743B1 (de)
AT (1)	ATE123948T1 (de)
AU (1)	AU633603B2 (de)
CA (1)	CA2022608A1 (de)
DE (1)	DE69020267T2 (de)
DK (1)	DK0416743T3 (de)
ES (1)	ES2073533T3 (de)
GB (1)	GB8918294D0 (de)
GR (1)	GR3016980T3 (de)
HK (1)	HK53496A (de)
IE (1)	IE67773B1 (de)
NO (1)	NO903509L (de)
NZ (1)	NZ234786A (de)
ZA (1)	ZA906187B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994392A (en) *	1988-02-26	1999-11-30	Neuromedica, Inc.	Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
GB8920228D0 (en) *	1989-09-07	1989-10-18	Efamol Holdings	Fatty acid therapy
US5214062A (en) *	1992-04-08	1993-05-25	Clintec Nutrition Co.	Method and composition for treating immune disorders, inflammation and chronic infections
GB9304746D0 (en) *	1993-03-09	1993-04-28	Scotia Holdings Plc	Treatment of viral infections
US5919815A (en) *	1996-05-22	1999-07-06	Neuromedica, Inc.	Taxane compounds and compositions
US5795909A (en)	1996-05-22	1998-08-18	Neuromedica, Inc.	DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en)	1996-05-22	2003-06-10	Protarga, Inc.	Method of treating a liver disorder with fatty acid-antiviral agent conjugates
ES2151277T3 (es) *	1996-05-22	2000-12-16	Protarga Inc	Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
US6225444B1 (en)	1998-02-10	2001-05-01	Protarga, Inc.	Neuroprotective peptides and uses thereof
RU2129011C1 (ru) *	1998-04-09	1999-04-20	Григорян Седа Суреновна	Способ интерферониндуцирующей или интерферонактивированной терапии и средство для его осуществления
US7235583B1 (en)	1999-03-09	2007-06-26	Luitpold Pharmaceuticals, Inc.,	Fatty acid-anticancer conjugates and uses thereof
US6426367B1 (en) *	1999-09-09	2002-07-30	Efa Sciences Llc	Methods for selectively occluding blood supplies to neoplasias
RU2222548C2 (ru) *	2000-07-21	2004-01-27	Зао "Ниармедик Плюс"	Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
EP1427407A4 (de)	2001-03-23	2005-05-11	Luitpold Pharm Inc	Fettamin-arzneimittel-konjugate
ES2387562T3 (es)	2001-03-23	2012-09-26	Luitpold Pharmaceuticals, Inc.	Conjugados alcohol graso-medicamento
RU2238122C1 (ru) *	2003-01-20	2004-10-20	Ооо "Ниармедик Плюс"	Противоинфекционный фармацевтический препарат
CA2436650A1 (en)	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
RU2270708C1 (ru) *	2004-05-26	2006-02-27	Ооо "Ниармедик Плюс"	Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9333242B2 (en)	2012-01-19	2016-05-10	Hybrid Medical, Llc	Topical therapeutic formulations
US10471131B2 (en)	2012-01-19	2019-11-12	Hybrid Medical, Llc	Topical therapeutic formulations
US9682055B2 (en)	2014-06-04	2017-06-20	Dignity Sciences Limted	Pharmaceutical compositions comprising DGLA and use of same
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2967049D1 (en) *	1978-04-11	1984-07-19	Efamol Ltd	Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4513008A (en) *	1982-07-30	1985-04-23	The Vinoxen Company, Inc.	Virucidal compositions and therapy
GB2134782B (en) *	1982-09-22	1987-03-04	Sentrachem Ltd	Anti-cancer compositions containing higher fatty acids
GB8319073D0 (en) *	1983-07-14	1983-08-17	Efamol Ltd	Fatty acid compositions
GB8507058D0 (en) *	1985-03-19	1985-04-24	Efamol Ltd	Pharmaceutical & dietary compositions
US5225441A (en) *	1987-06-18	1993-07-06	Block Drug Company, Inc.	Treatment of periodontal disease
US5116871A (en) *	1988-09-13	1992-05-26	Efamol Holdings Plc	Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis

1989
- 1989-08-10 GB GB898918294A patent/GB8918294D0/en active Pending
1990
- 1990-08-01 IE IE277490A patent/IE67773B1/en not_active IP Right Cessation
- 1990-08-02 AT AT90308542T patent/ATE123948T1/de not_active IP Right Cessation
- 1990-08-02 ES ES90308542T patent/ES2073533T3/es not_active Expired - Lifetime
- 1990-08-02 DE DE69020267T patent/DE69020267T2/de not_active Expired - Fee Related
- 1990-08-02 CA CA002022608A patent/CA2022608A1/en not_active Abandoned
- 1990-08-02 DK DK90308542.1T patent/DK0416743T3/da active
- 1990-08-02 EP EP90308542A patent/EP0416743B1/de not_active Expired - Lifetime
- 1990-08-02 EP EP94118597A patent/EP0678299A3/de not_active Withdrawn
- 1990-08-06 NZ NZ234786A patent/NZ234786A/en unknown
- 1990-08-06 ZA ZA906187A patent/ZA906187B/xx unknown
- 1990-08-06 AU AU60178/90A patent/AU633603B2/en not_active Ceased
- 1990-08-09 NO NO90903509A patent/NO903509L/no unknown
1995
- 1995-01-03 US US08/367,819 patent/US5580556A/en not_active Expired - Fee Related
- 1995-08-02 GR GR950402096T patent/GR3016980T3/el unknown
1996
- 1996-03-28 HK HK53496A patent/HK53496A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2022608A1 (en)	1991-02-11
AU6017890A (en)	1991-02-14
DE69020267D1 (de)	1995-07-27
GR3016980T3 (en)	1995-11-30
HK53496A (en)	1996-04-03
DK0416743T3 (da)	1995-08-14
EP0678299A2 (de)	1995-10-25
NO903509D0 (no)	1990-08-09
DE69020267T2 (de)	1996-01-25
EP0416743A1 (de)	1991-03-13
ZA906187B (en)	1991-06-26
EP0416743B1 (de)	1995-06-21
GB8918294D0 (en)	1989-09-20
NZ234786A (en)	1997-06-24
AU633603B2 (en)	1993-02-04
IE902774A1 (en)	1991-02-27
ES2073533T3 (es)	1995-08-16
EP0678299A3 (de)	1998-11-04
NO903509L (no)	1991-02-11
US5580556A (en)	1996-12-03
IE67773B1 (en)	1996-04-17

Legal Events

Date	Code	Title	Description
1996-02-15	UEP	Publication of translation of european patent specification
1999-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE123948T1 (de)	1995-07-15	Antiviral use of compositions comprising efas and interferon.
GR3006068T3 (de)	1993-06-21
DE3486235D1 (de)	1993-12-02	Fettsäure-Zusammensetzungen.
SE8902701L (sv)	1990-02-12	Fettsyrakomposition
ATE12732T1 (de)	1985-05-15	Pharmazeutische und diaetetische zusammensetzungen.
ATE50493T1 (de)	1990-03-15	Ibuprofen enthaltendes arzneimittel.
DK0572159T3 (da)	1998-03-09	Medikament til behandling af vulva dystrofi eller vaginal tørhed
ATE22532T1 (de)	1986-10-15	Pharmazeutische zusammensetzung.
ATE19855T1 (de)	1986-06-15	Pharmazeutische und diaetetische zusammensetzung.
AU570552B2 (en)	1988-03-17	1,4-dihydropyridine-3-carboxylates and salts thereof
DK0551729T3 (da)	1996-02-12	gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier
ATE145333T1 (de)	1996-12-15	Hirudin enthaltende orale arzneimittel
GB2208798B (en)	1991-06-05	Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
JPS5384581A (en)	1978-07-26	Semiconductor integrated circuit
IT1222736B (it)	1990-09-12	Dispositivo per l'accensione delle luci di arresto di veicoli ad intermittenza rapida e variabile
ES1008159Y (es)	1989-09-01	Mesa de billar perfeccionada.